SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Dec-23 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 11-Dec-23 | Payment of Exercise | 12,841 | $844.09 | $10,839,000.00 | (2%) 708.17K to 695.33K | |
13-Dec-23 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 11-Dec-23 | Option Exercise | 25,155 | -- | -- | 4% 683.02K to 708.17K | |
17-May-23 4:10 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-May-23 | Gift | 53,807 | -- | -- | 8% 683.02K to 736.82K | |
17-May-23 4:10 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-May-23 | Gift | 53,807 | -- | -- | (7%) 736.82K to 683.02K | |
07-Apr-22 4:04 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Apr-22 | Sale (Planned) | 2,653 | $710.04 | $1,883,740.00 | (< 1%) 685.63K to 682.97K | |
07-Apr-22 4:04 PM View: | Regeneron Pharmaceuticals I... (REGN) | 05-Apr-22 | Private Sale (Planned) | 4,461 | $710.05 | $3,167,530.00 | (< 1%) 690.09K to 685.63K | |
04-Apr-22 4:03 PM View: | Regeneron Pharmaceuticals I... (REGN) | 31-Mar-22 | Private Sale (Planned) | 2,886 | $710.01 | $2,049,090.00 | (< 1%) 692.97K to 690.09K | |
19-Nov-21 5:50 PM View: | Regeneron Pharmaceuticals I... (REGN) | 19-Nov-21 | Payment of Exercise | 359,137 | $651.96 | $234,143,008.00 | (34%) 1.05M to 692.97K | |
19-Nov-21 5:50 PM View: | Regeneron Pharmaceuticals I... (REGN) | 19-Nov-21 | Option Exercise | 520,313 | $221.08 | $115,030,000.00 | 98% 531.8K to 1.05M | |
17-Aug-21 10:00 PM View: | Regeneron Pharmaceuticals I... (REGN) | 16-Aug-21 | Market Sale (Planned) | 10,000 | $624.36 | $6,243,610.00 | (1%) 751.8K to 741.8K | (4%) |
10-Aug-21 5:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Aug-21 | Payment of Exercise | 228,575 | $607.51 | $138,862,000.00 | (23%) 980.37K to 751.8K | |
10-Aug-21 5:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Aug-21 | Option Exercise | 400,000 | $52.03 | $20,812,000.00 | 69% 580.37K to 980.37K | |
10-Aug-21 5:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 19-May-21 | Gift | 41,178 | -- | -- | 7% 580.37K to 621.55K | |
10-Aug-21 5:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 19-May-21 | Gift | 41,178 | -- | -- | (7%) 621.55K to 580.37K | |
13-May-20 9:01 PM View: | Regeneron Pharmaceuticals I... (REGN) | 12-May-20 | Market Option Sale (Planned) | 150,922 | $569.22 | $85,908,096.00 | (21%) 731.27K to 580.35K | 14% |
13-May-20 9:01 PM View: | Regeneron Pharmaceuticals I... (REGN) | 11-May-20 | Payment of Exercise | 161,578 | $571.43 | $92,330,496.00 | (18%) 892.85K to 731.27K | 14% |
13-May-20 9:01 PM View: | Regeneron Pharmaceuticals I... (REGN) | 11-May-20 | Option Exercise | 312,500 | $30.63 | $9,571,880.00 | 54% 580.35K to 892.85K | |
13-Dec-19 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 12-Dec-19 | Payment of Exercise | 161,963 | $377.16 | $61,086,000.00 | (22%) 742.28K to 580.32K | (30%) |
13-Dec-19 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 12-Dec-19 | Option Exercise | 312,400 | $21.25 | $6,638,500.00 | 73% 429.88K to 742.28K | |
22-Mar-19 4:03 PM View: | Regeneron Pharmaceuticals I... (REGN) | 21-Mar-19 | Option Exercise | 100 | $21.25 | $2,125.00 | < 1% 429.75K to 429.85K | |
14-Dec-18 4:19 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Dec-18 | Payment of Exercise | 160,131 | $377.31 | $60,419,000.00 | (27%) 589.85K to 429.72K | (30%) |
14-Dec-18 4:19 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Dec-18 | Option Exercise | 312,500 | $16.80 | $5,250,000.00 | 113% 277.35K to 589.85K | |
13-Dec-17 5:17 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Dec-17 | Payment of Exercise | 135,816 | $385.08 | $52,300,000.00 | (33%) 413.14K to 277.32K | (27%) |
13-Dec-17 5:17 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Dec-17 | Option Exercise | 250,000 | $21.92 | $5,480,000.00 | 153% 163.14K to 413.14K | |
19-Dec-16 4:07 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-Dec-16 | Payment of Exercise | 135,397 | $380.09 | $51,463,000.00 | (45%) 298.51K to 163.11K | (29%) |
19-Dec-16 4:07 PM View: | Regeneron Pharmaceuticals I... (REGN) | 15-Dec-16 | Option Exercise | 250,000 | $20.32 | $5,080,000.00 | 515% 48.51K to 298.51K | |
03-Sep-15 4:59 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Sep-15 | Payment of Exercise | 6,507 | $506.37 | $3,294,950.00 | (12%) 54.99K to 48.49K | 3% |
03-Sep-15 4:59 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Sep-15 | Option Exercise | 7,226 | $402.69 | $2,909,840.00 | 15% 47.77K to 54.99K | |
05-Jan-15 4:56 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Jan-15 | Conversion | 1,500 | -- | -- | 3% 47.74K to 49.24K | |
05-Jan-15 4:56 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Jan-15 | Market Sale (Planned) | 1,500 | $410.58 | $615,867.00 | (3%) 49.24K to 47.74K | (19%) |
12-Nov-14 5:14 PM View: | Regeneron Pharmaceuticals I... (REGN) | 12-Nov-14 | Market Sale (Planned) | 42,324 | $400.32 | $16,943,300.00 | (47%) 90.06K to 47.74K | (22%) |
12-Nov-14 5:14 PM View: | Regeneron Pharmaceuticals I... (REGN) | 11-Nov-14 | Market Sale (Planned) | 3,493 | $400.00 | $1,397,200.00 | (4%) 93.55K to 90.06K | (22%) |
04-Nov-14 4:06 PM View: | Regeneron Pharmaceuticals I... (REGN) | 31-Oct-14 | Market Sale (Planned) | 3,453 | $400.11 | $1,381,580.00 | (4%) 97.01K to 93.55K | (22%) |
29-Oct-14 4:27 PM View: | Regeneron Pharmaceuticals I... (REGN) | 28-Oct-14 | Market Option Sale (Planned) | 69,112 | $404.01 | $27,921,800.00 | (42%) 166.12K to 97.01K | (21%) |
29-Oct-14 4:27 PM View: | Regeneron Pharmaceuticals I... (REGN) | 27-Oct-14 | Payment of Exercise | 138,426 | $402.69 | $55,742,800.00 | (45%) 304.55K to 166.12K | (21%) |
29-Oct-14 4:27 PM View: | Regeneron Pharmaceuticals I... (REGN) | 27-Oct-14 | Option Exercise | 256,808 | $19.40 | $4,982,220.00 | 538% 47.74K to 304.55K | |
03-Oct-13 4:14 PM View: | Regeneron Pharmaceuticals I... (REGN) | 02-Oct-13 | Market Option Sale (Planned) | 9,162 | $313.82 | $2,875,250.00 | (16%) 56.87K to 47.7K | (56%) |
03-Oct-13 4:14 PM View: | Regeneron Pharmaceuticals I... (REGN) | 01-Oct-13 | Payment of Exercise | 20,114 | $313.58 | $6,307,350.00 | (26%) 76.98K to 56.87K | (56%) |
03-Oct-13 4:14 PM View: | Regeneron Pharmaceuticals I... (REGN) | 01-Oct-13 | Option Exercise | 29,276 | $111.01 | $3,249,930.00 | 61% 47.7K to 76.98K | |
20-Sep-13 4:25 PM View: | Regeneron Pharmaceuticals I... (REGN) | 19-Sep-13 | Market Option Sale (Planned) | 102,949 | $302.67 | $31,159,200.00 | (68%) 150.65K to 47.7K | (62%) |
20-Sep-13 4:25 PM View: | Regeneron Pharmaceuticals I... (REGN) | 18-Sep-13 | Payment of Exercise | 115,440 | $304.38 | $35,137,600.00 | (43%) 266.09K to 150.65K | (61%) |
20-Sep-13 4:25 PM View: | Regeneron Pharmaceuticals I... (REGN) | 18-Sep-13 | Option Exercise | 218,389 | $9.49 | $2,072,510.00 | 458% 47.7K to 266.09K | |
11-Sep-13 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 09-Sep-13 | Conversion | 5,000 | -- | -- | 10% 47.7K to 52.7K | |
11-Sep-13 4:05 PM View: | Regeneron Pharmaceuticals I... (REGN) | 09-Sep-13 | Market Sale (Planned) | 5,000 | $275.47 | $1,377,330.00 | (9%) 52.7K to 47.7K | (77%) |
03-May-13 4:09 PM View: | Regeneron Pharmaceuticals I... (REGN) | 01-May-13 | Market Sale (Planned) | 100,000 | $237.65 | $23,765,300.00 | (68%) 147.71K to 47.7K | (106%) |
21-Mar-13 4:18 PM View: | Regeneron Pharmaceuticals I... (REGN) | 19-Mar-13 | Market Sale (Planned) | 3,655 | $175.02 | $639,698.00 | (2%) 151.36K to 147.71K | (179%) |
15-Mar-13 5:03 PM View: | Regeneron Pharmaceuticals I... (REGN) | 13-Mar-13 | Market Sale (Planned) | 4,662 | $175.01 | $815,897.00 | (3%) 156.02K to 151.36K | (179%) |
07-Mar-13 5:08 PM View: | Regeneron Pharmaceuticals I... (REGN) | 07-Mar-13 | Market Sale (Planned) | 3,534 | $175.13 | $618,909.00 | (2%) 159.56K to 156.02K | (179%) |
07-Mar-13 5:08 PM View: | Regeneron Pharmaceuticals I... (REGN) | 06-Mar-13 | Market Sale (Planned) | 69,003 | $175.38 | $12,101,600.00 | (30%) 228.56K to 159.56K | (179%) |
07-Mar-13 5:08 PM View: | Regeneron Pharmaceuticals I... (REGN) | 05-Mar-13 | Market Sale (Planned) | 19,146 | $175.21 | $3,354,570.00 | (8%) 247.71K to 228.56K | (179%) |